Haipeng Tao

650 total citations
10 papers, 488 citations indexed

About

Haipeng Tao is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Haipeng Tao has authored 10 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Haipeng Tao's work include CAR-T cell therapy research (6 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers) and Glioma Diagnosis and Treatment (3 papers). Haipeng Tao is often cited by papers focused on CAR-T cell therapy research (6 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers) and Glioma Diagnosis and Treatment (3 papers). Haipeng Tao collaborates with scholars based in United States and China. Haipeng Tao's co-authors include Jianping Huang, Elias Sayour, Duane A. Mitchell, Linchun Jin, Yu Long, Aida Karachi, Maryam Rahman, Loic P. Deleyrolle, Adam Grippin and Zhiguo Lin and has published in prestigious journals such as Nature Communications, Cancer Research and Acta Biomaterialia.

In The Last Decade

Haipeng Tao

9 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haipeng Tao United States 5 350 193 132 116 79 10 488
Alicia Y. Hou United States 3 293 0.8× 160 0.8× 108 0.8× 97 0.8× 83 1.1× 5 396
Akane Yamamichi Japan 12 221 0.6× 108 0.6× 147 1.1× 90 0.8× 48 0.6× 25 400
Aubrey S. Smith United States 11 431 1.2× 317 1.6× 138 1.0× 94 0.8× 77 1.0× 18 560
Genevieve M. Gerhard United States 5 315 0.9× 250 1.3× 235 1.8× 82 0.7× 84 1.1× 7 621
Paris Kosti United Kingdom 7 395 1.1× 232 1.2× 185 1.4× 135 1.2× 95 1.2× 9 509
Malvina Prapa Italy 7 198 0.6× 87 0.5× 139 1.1× 83 0.7× 47 0.6× 10 350
Alfonso Brito United States 6 588 1.7× 245 1.3× 225 1.7× 254 2.2× 128 1.6× 20 735
Yansha Sun China 11 517 1.5× 295 1.5× 162 1.2× 148 1.3× 96 1.2× 20 617
Aniee Sarkissian United States 5 466 1.3× 194 1.0× 145 1.1× 224 1.9× 107 1.4× 8 575
Michael R. Weist United States 6 215 0.6× 94 0.5× 95 0.7× 123 1.1× 42 0.5× 8 352

Countries citing papers authored by Haipeng Tao

Since Specialization
Citations

This map shows the geographic impact of Haipeng Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haipeng Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haipeng Tao more than expected).

Fields of papers citing papers by Haipeng Tao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haipeng Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haipeng Tao. The network helps show where Haipeng Tao may publish in the future.

Co-authorship network of co-authors of Haipeng Tao

This figure shows the co-authorship network connecting the top 25 collaborators of Haipeng Tao. A scholar is included among the top collaborators of Haipeng Tao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haipeng Tao. Haipeng Tao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Liu, Qi, Yu‐Ming Wang, Tianyi Liu, et al.. (2025). Enhanced antitumor immunity of VNP20009-CCL2-CXCL9 via the cGAS/STING axis in osteosarcoma lung metastasis. Journal for ImmunoTherapy of Cancer. 13(7). e012269–e012269. 1 indexed citations
2.
Ligon, John A., Paul Castillo, Xiaojie Ma, et al.. (2024). CD70 CXCR2-Modified CAR T-Cells Against Acute Myeloid Leukemia. Transplantation and Cellular Therapy. 30(2). S178–S179. 1 indexed citations
3.
Ogando‐Rivas, Elizabeth, John A. Ligon, Linchun Jin, et al.. (2023). Bioconjugated liquid-like solid enhances characterization of solid tumor - chimeric antigen receptor T cell interactions. Acta Biomaterialia. 172. 466–479. 9 indexed citations
4.
Ogando‐Rivas, Elizabeth, Ruixuan Liu, Theodore Wang, et al.. (2022). CAR T Cell Locomotion in Solid Tumor Microenvironment. Cells. 11(12). 1974–1974. 35 indexed citations
5.
Jin, Linchun, Haipeng Tao, Na Meng, et al.. (2020). IMMU-38. PRECLINICAL VALIDATION AND MANUFACTURE OF IL-8 RECEPTOR-MODIFIED CD70 CAR T CELLS FOR CLINICAL TRIAL. Neuro-Oncology. 22(Supplement_2). ii113–ii113.
6.
Long, Yu, Haipeng Tao, Aida Karachi, et al.. (2019). Dysregulation of Glutamate Transport Enhances Treg Function That Promotes VEGF Blockade Resistance in Glioblastoma. Cancer Research. 80(3). 499–509. 93 indexed citations
7.
Meng, Na, Linchun Jin, Haipeng Tao, et al.. (2019). IMMU-26. RADIATION AND TEMOZOLOMIDE UP-REGULATES CD70 EXPRESSION AND ENHANCES CAR T- CELL RECOGNITION IN GBM. Neuro-Oncology. 21(Supplement_6). vi124–vi124. 1 indexed citations
8.
Jin, Linchun, Haipeng Tao, Aida Karachi, et al.. (2019). CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors. Nature Communications. 10(1). 4016–4016. 285 indexed citations
9.
Long, Yu, Aida Karachi, Adam Grippin, et al.. (2018). DRES-13. VEGF BLOCKADE ENHANCES T REGULATORY CELL FUNCTION BY DYSREGULATING GLUTAMATE TRANSPORT IN GBM. Neuro-Oncology. 20(suppl_6). vi78–vi78. 1 indexed citations
10.
Mu, Luyan, Yu Long, Changlin Yang, et al.. (2018). The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas. Frontiers in Molecular Neuroscience. 11. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026